Axonis Therapeutics is a Boston-based, neuro-focused biotechnology company developing first- and best-in-class medicines targeting KCC2, the critical mediator of inhibition within the brain, by translating breakthrough discoveries spun out from Boston Children’s Hospital, Harvard and Laval University. We are an exceptional team of drug hunters and target biology experts who have built a proprietary KCC2 discovery engine based on several years of world-leading know-how, to become the leaders in this potential blockbuster drug space. A venBio portfolio company, Axonis has raised $34+M in dilutive Seed funding, and $8+M in competitive non-dilutive grants/awards, to support our mission of improving the lives of people suffering from neurological disorders. First-in-human trials will begin in 2024 for the first-in-class oral KCC2 potentiator drug, AXN-027, designed for fine-tuning inhibition to treat epilepsy, pain and other CNS pathologies.
View Top Employees from AXONIS TherapeuticsWebsite | http://www.axonis.us |
Revenue | $3 million |
Employees | 19 (14 on RocketReach) |
Founded | 2019 |
Address | 75 Kneeland St 14th Floor, Boston, Massachusetts 02111, US |
Phone | (949) 933-2341 |
Technologies |
JavaScript,
HTML,
PHP
+20 more
(view full list)
|
Industry | Biotechnology, Business Services General, Business Services, Drug Discovery, Gene Therapy, Spinal Cord Injury, Neuroregeneration, Axon Regeneration, Adeno-associated Virus, AAV, Shrna, RNA interference |
Competitors | AivoCode, August Therapeutics, Inc, Convelo Therapeutics, Inc, Neurofix Pharma S.A., PharmatrophiX, Inc. |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 541714 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 541 Companies |
Looking for a particular AXONIS Therapeutics employee's phone or email?
The AXONIS Therapeutics annual revenue was $3 million in 2024.
Joanna Stanicka is the CEO of AXONIS Therapeutics.
14 people are employed at AXONIS Therapeutics.
AXONIS Therapeutics is based in Boston, Massachusetts.
The NAICS codes for AXONIS Therapeutics are [541714, 54, 5417, 54171, 541].
The SIC codes for AXONIS Therapeutics are [873, 87].